Skip to main content
logo
ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
4.770
-0.050 (-1.04%)
Oct 27, 2026, 1:16 PM EDT - Market open

ENDRA Life Sciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
------
Revenue Growth
------
Gross Profit
------
Operating Income
-6.65-5.76-10.82-10.52-13.16-11.5
Net Income
-5.92-7.03-11.51-10.06-13.18-11.35
Earnings Per Share
-5.38-8.93-56.94---
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.740.763.232.834.899.46
Total Debt
0.430.490.580.540.710.8
Net Cash (Debt)
1.310.272.652.294.188.67
Net Cash Growth
4.76%-89.79%15.47%-45.25%-51.72%34.18%
Net Cash Per Share
1.190.3413.09---

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-4.82-5.18-7.4-9.55-12.77-11.12
Capital Expenditures
-0.02-0.02-0.02-0.03-0.2-0.05
Free Cash Flow
-4.84-5.2-7.42-9.58-12.97-11.17
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
------
Profit Margin
------
FCF Margin
------

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
------